Type |
Details |
Score |
Publication |
First Author: |
Readinger JA |
Year: |
2009 |
Journal: |
Immunol Rev |
Title: |
Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk. |
Volume: |
228 |
Issue: |
1 |
Pages: |
93-114 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yoshida K |
Year: |
2000 |
Journal: |
J Biol Chem |
Title: |
Mediation by the protein-tyrosine kinase Tec of signaling between the B cell antigen receptor and Dok-1. |
Volume: |
275 |
Issue: |
32 |
Pages: |
24945-52 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 3, Hisamaru Hirai |
Allele Type: |
Transgenic |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 5, Hisamaru Hirai |
Allele Type: |
Transgenic |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion, Hisamaru Hirai |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 1, Hisamaru Hirai |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Publication |
First Author: |
Smith CI |
Year: |
2001 |
Journal: |
Bioessays |
Title: |
The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species. |
Volume: |
23 |
Issue: |
5 |
Pages: |
436-46 |
|
•
•
•
•
•
|
Publication |
First Author: |
Miyazaki K |
Year: |
2009 |
Journal: |
Blood |
Title: |
Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia. |
Volume: |
113 |
Issue: |
19 |
Pages: |
4702-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Takita M |
Year: |
2018 |
Journal: |
Oncotarget |
Title: |
Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABL. |
Volume: |
9 |
Issue: |
60 |
Pages: |
31682-31696 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mizuno T |
Year: |
2008 |
Journal: |
Oncogene |
Title: |
Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice. |
Volume: |
27 |
Issue: |
24 |
Pages: |
3465-74 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, congenic, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Sánchez-Sánchez B |
Year: |
2014 |
Journal: |
Clin Cancer Res |
Title: |
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia. |
Volume: |
20 |
Issue: |
15 |
Pages: |
4014-25 |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
E-GEOD-53110 |
Experiment Type: |
RNA-Seq |
Study Type: |
WT vs. Mutant |
Source: |
GEO |
|
•
•
•
•
•
|
Publication |
First Author: |
Boggon TJ |
Year: |
2004 |
Journal: |
Oncogene |
Title: |
Structure and regulation of Src family kinases. |
Volume: |
23 |
Issue: |
48 |
Pages: |
7918-27 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schwartzberg PL |
Year: |
2005 |
Journal: |
Nat Rev Immunol |
Title: |
TEC-family kinases: regulators of T-helper-cell differentiation. |
Volume: |
5 |
Issue: |
4 |
Pages: |
284-95 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SH3 domain of Tec [, ]. Tec is a cytoplasmic (or nonreceptor) tyrosine kinase containing Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain []. It also contains an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation, and the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions []. It is more widely-expressed than other Tec subfamily kinases. Tec is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils [, ]. Tec is a key component of T-cell receptor (TCR) signaling, and is important in TCR-stimulated proliferation and phospholipase C-gamma1 activation []. |
|
•
•
•
•
•
|
Publication |
First Author: |
August A |
Year: |
1994 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. |
Volume: |
91 |
Issue: |
20 |
Pages: |
9347-51 |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
WT vs. Mutant |
Source: |
GEO |
|
•
•
•
•
•
|
Allele |
Name: |
KIT proto-oncogene receptor tyrosine kinase; banded |
Allele Type: |
Spontaneous |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Jain N |
Year: |
2013 |
Journal: |
Nat Med |
Title: |
CD28 and ITK signals regulate autoreactive T cell trafficking. |
Volume: |
19 |
Issue: |
12 |
Pages: |
1632-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Klüppel M |
Year: |
1997 |
Journal: |
Development |
Title: |
Long-range genomic rearrangements upstream of Kit dysregulate the developmental pattern of Kit expression in W57 and Wbanded mice and interfere with distinct steps in melanocyte development. |
Volume: |
124 |
Issue: |
1 |
Pages: |
65-77 |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
E-GEOD-65617 |
Experiment Type: |
RNA-Seq |
Study Type: |
WT vs. Mutant |
Source: |
GEO |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
STAP1 and STAP2 are signal-transducing adaptor proteins. They contain Pleckstrin Homology (PH) and SH2 domains along with several tyrosine phosphorylation sites.STAP1 functions as a docking protein acting downstream of Tec tyrosine kinase in B cell antigen receptor signaling. It is phosphorylated by Tec and participates in a positive feedback loop, increasing Tec activity []. STAP-1 has been shown to interact with STAT5 []. STAP2 is a substrate of breast tumour kinase, an Src-type non-receptor tyrosine kinase that mediates the interactions linking proteins involved in signal transduction pathways []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Honda H |
Year: |
1998 |
Journal: |
Blood |
Title: |
Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias. |
Volume: |
91 |
Issue: |
6 |
Pages: |
2067-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sekine Y |
Year: |
2005 |
Journal: |
J Biol Chem |
Title: |
Physical and functional interactions between STAP-2/BKS and STAT5. |
Volume: |
280 |
Issue: |
9 |
Pages: |
8188-96 |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
Baseline |
Source: |
GEO |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Txk is a member of the Tec protein tyrosine kinase family. It plays a role in TCR signal transduction, T cell development, and selection which is analogous to the function of Itk. Txk has been shown to interact with IFN-gamma [, ]. Unlike most of the Tec family members Txk lacks a PH domain. Instead Txk has a unique region containing a palmitoylated cysteine string which has a similar membrane tethering function as the PH domain []. This entry includes the SH2 domain of Txk.The Tec protein tyrosine kinase family includes Tec,Btk, Itk, Bmx, and Txk. They contain an NH2-terminal pleckstrin homology (PH) domain (absent in Txk), a proline-rich region, Src-homology 3 (SH3) and SH2 domains, and a COOH-terminal PTK domain. The TH domain consists of a Zn2+-binding Btk motif and a proline-rich region. The Btk motif is found in Tec kinases, Ras GAP, and IGBP and crucial to the function of the PH domain. It is not present in Txk which is not surprising since it lacks a PH domain. The type 1 splice form of the Drosophila homologue also lacks both the PH domain and the Btk motif. The proline-rich regions are highly conserved for the most part with the exception of Bmx whose residues surrounding the PXXP motif are not conserved (TH-like) and Btk29A which is entirely unique with large numbers of glycine residues (TH-extended). Tec family members all lack a C-terminal tyrosine having an autoinhibitory function in its phosphorylated state [, ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Contreras CM |
Year: |
2007 |
Journal: |
Mol Immunol |
Title: |
Btk regulates multiple stages in the development and survival of B-1 cells. |
Volume: |
44 |
Issue: |
10 |
Pages: |
2719-28 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
spontaneous mutation, inversion, mutant stock |
|
•
•
•
•
•
|
Publication |
First Author: |
Klüppel M |
Year: |
1998 |
Journal: |
Dev Dyn |
Title: |
Developmental origin and Kit-dependent development of the interstitial cells of cajal in the mammalian small intestine. |
Volume: |
211 |
Issue: |
1 |
Pages: |
60-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Beechey CV |
Year: |
1986 |
Journal: |
Mouse News Lett |
Title: |
Banded - a new W allele |
Volume: |
74 |
|
Pages: |
92 |
|
•
•
•
•
•
|
Publication |
First Author: |
Beechey CV |
Year: |
1994 |
Journal: |
Mouse Genome |
Title: |
A new spontaneous W allele, W36H |
Volume: |
92 |
Issue: |
3 |
Pages: |
502 |
|
•
•
•
•
•
|
Publication |
First Author: |
Beechey CV |
Year: |
1983 |
Journal: |
Mouse News Lett |
Title: |
Two new W mutations |
Volume: |
68 |
|
Pages: |
70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sanada M |
Year: |
2009 |
Journal: |
Nature |
Title: |
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. |
Volume: |
460 |
Issue: |
7257 |
Pages: |
904-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Di Cristofano A |
Year: |
2001 |
Journal: |
J Exp Med |
Title: |
p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). |
Volume: |
194 |
Issue: |
3 |
Pages: |
275-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Seo S |
Year: |
2011 |
Journal: |
Cancer Sci |
Title: |
Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl. |
Volume: |
102 |
Issue: |
12 |
Pages: |
2109-17 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dok1/Dok1 Tg(Tec-BCR/ABL1)5Hhi/? |
Background: |
involves: C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dok2/Dok2 Tg(Tec-BCR/ABL1)5Hhi/? |
Background: |
involves: C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dok1/Dok1<+> Tg(Tec-BCR/ABL1)5Hhi/? |
Background: |
involves: 129S1/Sv |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dok2/Dok2<+> Tg(Tec-BCR/ABL1)5Hhi/? |
Background: |
involves: 129S1/Sv |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dok1/Dok1 Tg(Tec-BCR/ABL1)5Hhi/? |
Background: |
involves: 129S1/Sv |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dok2/Dok2 Tg(Tec-BCR/ABL1)5Hhi/? |
Background: |
involves: 129S1/Sv |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Kit/Kit<+> |
Background: |
involves: STOCK Rw Fgf5 Vps33a |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Kit/Kit |
Background: |
involves: STOCK Rw Fgf5 Vps33a |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Kit/Kit |
Background: |
involves: 101/H * C3H/HeH * STOCK Rw Fgf5 Vps33a |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cbl/Cbl<+> Tg(Tec-BCR/ABL1)5Hhi/? |
Background: |
involves: C57BL/6 * DBA/2 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cbl/Cbl Tg(Tec-BCR/ABL1)5Hhi/? |
Background: |
involves: C57BL/6 * DBA/2 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
STAP1 is a signal-transducing adaptor protein. It is composed of a Pleckstrin Homology (PH) and SH2 domains along with several tyrosine phosphorylation sites. STAP-1 is an orthologue of BRDG1 (also known as BCR downstream signaling 1). STAP1 protein functions as a docking protein acting downstream of Tec tyrosine kinase in B cell antigen receptor signaling. The protein is phosphorylated by Tec and participates in a positive feedback loop, increasing Tec activity []. STAP-1 has been shown to interact with STAT5 []. This entry represents the SH2 domain of STAP1.In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites [, , ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
TXK is a member of the Tec family, which is a group of nonreceptor tyrosine kinases containing Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. It also contains an N-terminal cysteine-rich region. TXK forms a complex with EF-1alpha and PARP1 that regulates interferon-gamma gene transcription in Th1 cells []. This entry represents the SH3 domain of TXK. |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
Baseline |
Source: |
GEO |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
Baseline |
Source: |
GEO |
|
•
•
•
•
•
|
Publication |
First Author: |
Hiroki H |
Year: |
2023 |
Journal: |
Sci Rep |
Title: |
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells. |
Volume: |
13 |
Issue: |
1 |
Pages: |
7588 |
|
•
•
•
•
•
|
Publication |
First Author: |
Honda H |
Year: |
2000 |
Journal: |
Blood |
Title: |
Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML. |
Volume: |
95 |
Issue: |
4 |
Pages: |
1144-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yasuda T |
Year: |
2004 |
Journal: |
J Exp Med |
Title: |
Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. |
Volume: |
200 |
Issue: |
12 |
Pages: |
1681-7 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Dok1/Dok1 Dok2/Dok2 Tg(Tec-BCR/ABL1)5Hhi/? |
Background: |
involves: C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
Baseline |
Source: |
GEO |
|
•
•
•
•
•
|
Publication |
First Author: |
Kosaka Y |
Year: |
2006 |
Journal: |
Trends Immunol |
Title: |
Itk and Th2 responses: action but no reaction. |
Volume: |
27 |
Issue: |
10 |
Pages: |
453-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang YH |
Year: |
2007 |
Journal: |
Science |
Title: |
Positive regulation of Itk PH domain function by soluble IP4. |
Volume: |
316 |
Issue: |
5826 |
Pages: |
886-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
King PD |
Year: |
1998 |
Journal: |
Int Immunol |
Title: |
CD2-mediated activation of the Tec-family tyrosine kinase ITK is controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail. |
Volume: |
10 |
Issue: |
7 |
Pages: |
1009-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ikeda O |
Year: |
2011 |
Journal: |
Cancer Sci |
Title: |
Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells. |
Volume: |
102 |
Issue: |
4 |
Pages: |
756-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brown K |
Year: |
2004 |
Journal: |
J Biol Chem |
Title: |
Crystal structures of interleukin-2 tyrosine kinase and their implications for the design of selective inhibitors. |
Volume: |
279 |
Issue: |
18 |
Pages: |
18727-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tsoukas CD |
Year: |
2006 |
Journal: |
Adv Exp Med Biol |
Title: |
Inducible T cell tyrosine kinase (ITK): structural requirements and actin polymerization. |
Volume: |
584 |
|
Pages: |
29-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kutach AK |
Year: |
2010 |
Journal: |
Chem Biol Drug Des |
Title: |
Crystal structures of IL-2-inducible T cell kinase complexed with inhibitors: insights into rational drug design and activity regulation. |
Volume: |
76 |
Issue: |
2 |
Pages: |
154-63 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
PTKs catalyse the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk, also known as Tsk or Emt, is a member of the Tec-like subfamily of proteins, which are cytoplasmic (or nonreceptor) PTKs with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members except Rlk also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region [, ].Itk is expressed in T-cells and mast cells, and is important in their development and differentiation []. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signalling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization []. It also plays a role in the downstream signalling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4 [, ]. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
ITK (also known as Tsk or Emt) is a member of the Tec family, which is a group of nonreceptor tyrosine kinases containing Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. It also contains an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation [], and the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. ITK is expressed in T-cells and mast cells, and is important in their development and differentiation [, ]. Of the three Tec kinases expressed in T-cells, ITK plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization []. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28 [], the T-cell surface receptor CD2 [], and the chemokine receptor CXCR4 []. In addition, ITK is crucial for the development of T-helper(Th)2 effector responses []. This entry represents the SH3 domain of ITK. |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
E-GEOD-44945 |
Experiment Type: |
RNA-Seq |
Study Type: |
Baseline |
Source: |
GEO |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamanashi Y |
Year: |
2000 |
Journal: |
Genes Dev |
Title: |
Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. |
Volume: |
14 |
Issue: |
1 |
Pages: |
11-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gómez C |
Year: |
2022 |
Journal: |
Cancers (Basel) |
Title: |
Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia. |
Volume: |
14 |
Issue: |
16 |
|
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
WT vs. Mutant |
Source: |
GEO |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
WT vs. Mutant |
Source: |
GEO |
|
•
•
•
•
•
|
Publication |
First Author: |
Tate G |
Year: |
1996 |
Journal: |
Cytogenet Cell Genet |
Title: |
Localization of the human IL-2-inducible T-cell kinase gene (ITK) to chromosome band 5q34 and the mouse gene (Itk) to chromosome 15 by fluorescence in situ hybridization. |
Volume: |
74 |
Issue: |
1-2 |
Pages: |
96-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hyvönen M |
Year: |
1997 |
Journal: |
EMBO J |
Title: |
Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia. |
Volume: |
16 |
Issue: |
12 |
Pages: |
3396-404 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vihinen M |
Year: |
1997 |
Journal: |
FEBS Lett |
Title: |
Missense mutations affecting a conserved cysteine pair in the TH domain of Btk. |
Volume: |
413 |
Issue: |
2 |
Pages: |
205-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jiang Y |
Year: |
1998 |
Journal: |
Nature |
Title: |
The G protein G alpha12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain. |
Volume: |
395 |
Issue: |
6704 |
Pages: |
808-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lindvall JM |
Year: |
2005 |
Journal: |
Immunol Rev |
Title: |
Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. |
Volume: |
203 |
|
Pages: |
200-15 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Conserved_site |
Description: |
The Btk-type zinc finger or Btk motif (BM) is a conserved zinc-binding motif containing conserved cysteines and a histidine that is present in certain eukaryotic signalling proteins. The motif is named after Bruton's tyrosine kinase (Btk), an enzyme which is essential for B cell maturation in humans and mice [, ]. Btk is a member of the Tec family of protein tyrosine kinases (PTK). These kinases contain a conserved Tec homology (TH) domain between the N-terminal pleckstrin homology (PH) domain () and the Src homology 3 (SH3) domain (). The N-terminal of the TH domain is highly conserved and known as the Btf motif, while the C-terminal region of the TH domain contains a proline-rich region (PRR). The Btk motif contains a conserved His and three Cys residues that form a zinc finger (although these differ from known zinc finger topologies), while PRRs are commonly involved in protein-protein interactions, including interactions with G proteins [, ]. The TH domain may be of functional importance in various signalling pathways in different species []. A complete TH domain, containing both the Btk and PRR regions, has not been found outside the Tec family; however, the Btk motif on its own does occur in other proteins, usually C-terminal to a PH domain (note that although a Btk motif always occurs C-terminal to a PH domain, not all PH domains are followed by a Btk motif).The crystal structures of Btk show that the Btk-type zinc finger has a globular core, formed by a long loop which is held together by a zinc ion, and that the Btk motif is packed against the PH domain []. The zinc-binding residues are a histidine and three cysteines, which are fully conserved in the Btk motif []. Proteins known to contain a Btk-type zinc finger include:Mammalian Bruton's tyrosine kinase (Btk), a protein tyrosine kinase involved in modulation of diverse cellular processes. Mutations affecting Btk are the cause of X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency in mice. Mammalian Tec, Bmx, and Itk proteins, which are tyrosine protein kinases of the Tec subfamily. Drosophila tyrosine-protein kinase Btk29A, which is required for the development of proper ring canals and of male genitalia and required for adult survival. Mammalian Ras GTPase-activating proteins (RasGAP), which regulate the activation of inactive GDP-bound Ras by converting GDP to GTP. |
|
•
•
•
•
•
|
Publication |
First Author: |
Mesci L |
Year: |
2006 |
Journal: |
Turk J Pediatr |
Title: |
A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase. |
Volume: |
48 |
Issue: |
4 |
Pages: |
362-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vihinen M |
Year: |
2000 |
Journal: |
Front Biosci |
Title: |
Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA). |
Volume: |
5 |
|
Pages: |
D917-28 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brunner C |
Year: |
2005 |
Journal: |
Histol Histopathol |
Title: |
Bruton's Tyrosine Kinase is involved in innate and adaptive immunity. |
Volume: |
20 |
Issue: |
3 |
Pages: |
945-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kang SW |
Year: |
2001 |
Journal: |
EMBO J |
Title: |
PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization. |
Volume: |
20 |
Issue: |
20 |
Pages: |
5692-702 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Btk (Bruton tyrosine kinase) is a member of the Tec family, which is a group of nonreceptor tyrosine kinases containing Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Btk also contains an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation, and the Tec homology (TH) domain with proline-rich and zinc-binding regions [].Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells [, ]. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation []. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis []. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans [, ]. This entry represents the SH3 domain of Btk. |
|
•
•
•
•
•
|
Publication |
First Author: |
Sato T |
Year: |
2014 |
Journal: |
Oncogene |
Title: |
Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia. |
Volume: |
33 |
Issue: |
42 |
Pages: |
5028-38 |
|
•
•
•
•
•
|
Publication |
First Author: |
Barford D |
Year: |
1998 |
Journal: |
Structure |
Title: |
Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2. |
Volume: |
6 |
Issue: |
3 |
Pages: |
249-54 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
123
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
259
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
259
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Sano S |
Year: |
2001 |
Journal: |
Immunity |
Title: |
Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. |
Volume: |
15 |
Issue: |
2 |
Pages: |
261-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Su DM |
Year: |
2003 |
Journal: |
Nat Immunol |
Title: |
A domain of Foxn1 required for crosstalk-dependent thymic epithelial cell differentiation. |
Volume: |
4 |
Issue: |
11 |
Pages: |
1128-35 |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
Baseline |
Source: |
GEO |
|
•
•
•
•
•
|
Publication |
First Author: |
Rajagopal K |
Year: |
1999 |
Journal: |
J Exp Med |
Title: |
RIBP, a novel Rlk/Txk- and itk-binding adaptor protein that regulates T cell activation. |
Volume: |
190 |
Issue: |
11 |
Pages: |
1657-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kohmura N |
Year: |
1994 |
Journal: |
Mol Cell Biol |
Title: |
A novel nonreceptor tyrosine kinase, Srm: cloning and targeted disruption. |
Volume: |
14 |
Issue: |
10 |
Pages: |
6915-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tian H |
Year: |
2019 |
Journal: |
Biochem Biophys Res Commun |
Title: |
SHP-1 inhibits renal ischemia reperfusion injury via dephosphorylating ASK1 and suppressing apoptosis. |
Volume: |
513 |
Issue: |
2 |
Pages: |
360-367 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mizuno T |
Year: |
2003 |
Journal: |
J Immunol |
Title: |
Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B. |
Volume: |
170 |
Issue: |
6 |
Pages: |
2806-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alves NL |
Year: |
2010 |
Journal: |
J Immunol |
Title: |
Cutting Edge: a thymocyte-thymic epithelial cell cross-talk dynamically regulates intrathymic IL-7 expression in vivo. |
Volume: |
184 |
Issue: |
11 |
Pages: |
5949-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ciornei RT |
Year: |
2016 |
Journal: |
Cell Immunol |
Title: |
Mechanisms and kinetics of proliferation and fibrosis development in a mouse model of thyrocyte hyperplasia. |
Volume: |
304-305 |
|
Pages: |
16-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Block H |
Year: |
2012 |
Journal: |
J Exp Med |
Title: |
Crucial role of SLP-76 and ADAP for neutrophil recruitment in mouse kidney ischemia-reperfusion injury. |
Volume: |
209 |
Issue: |
2 |
Pages: |
407-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kayes TD |
Year: |
2013 |
Journal: |
Cell Immunol |
Title: |
Culture promotes transfer of thyroid epithelial cell hyperplasia and proliferation by reducing regulatory T cell numbers. |
Volume: |
285 |
Issue: |
1-2 |
Pages: |
84-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kannan AK |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
T-Bet independent development of IFNγ secreting natural T helper 1 cell population in the absence of Itk. |
Volume: |
7 |
|
Pages: |
45935 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yu S |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
TGF-beta promotes thyroid epithelial cell hyperplasia and fibrosis in IFN-gamma-deficient NOD.H-2h4 mice. |
Volume: |
181 |
Issue: |
3 |
Pages: |
2238-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lopes N |
Year: |
2017 |
Journal: |
EMBO Mol Med |
Title: |
Administration of RANKL boosts thymic regeneration upon bone marrow transplantation. |
Volume: |
9 |
Issue: |
6 |
Pages: |
835-851 |
|
•
•
•
•
•
|